Criminal Code Act 1995

Pt 9.1 inserted by No 129 of 2005, s 3 and Sch 1 item 1, effective 6 December 2005.

Div 314 repealed by No 167 of 2012, s 3 and Sch 1 item 19, applicable in relation to offences against Part 9.1 of the Criminal Code that are committed on or after 29 May 2013. Div 314 formerly read:

Division 314 - Drugs, plants, precursors and quantities

SECTION 314.1 Controlled drugs  
(1)
The following table lists controlled drugs and sets out quantities:

Controlled drugs and quantities
Controlled drug	Trafficable	Marketable	Commercial
	quantity	quantity	quantity
	(grams)	(grams)	(kilograms)
1     Amphetamine	2.0	250.0	0.75
1A     Benzylpiperazine (BZP)	2.0	250.0	0.75
2     Cannabis (in any form, including flowering or fruiting tops, leaves, seeds or stalks, but not including Cannabis resin or Cannabis fibre)	250.0	25,000.0	125.0
3     Cannabis resin	20.0	25,000.0	125.0
4     Cocaine	2.0	250.0	2.0
5     Gammabutyrolactone (GBL)	0.5	250.0	1.0
6     4-Hydroxybutanoic acid (GHB)	0.5	250.0	1.0
7     Heroin (diacetylmorphine)	2.0	250.0	1.5
7A     Ketamine	3.0	500.0	1.0
8     Lysergide (LSD)	0.002	0.05	0.002
9     Methamphetamine	2.0	250.0	0.75
9A     Methcathinone	2.0	250.0	0.75
10   3,4-Methylenedioxyamphetamine (MDA)	0.5	100.0	0.75
11   3,4-Methylenedioxymethamphetamine (MDMA)	0.5	100.0	0.5
11A     4-Methylmethcathinone (4-MMC)	2.0	250.0	0.75
12   Opium	20.0	10,000.0	20.0
13   Psilocine	2.0	1,000.0	2.0
14   Psilocybine	2.0	1,000.0	2.0
15   Tetrahydrocannabinol (THC)	2.0	1,000.0	5.0

 View history note

 Hide history note

History

S 314.1(1) amended by No 24 of 2012, s 3 and Sch 5 items 1 - 4, by inserting table items 1A, 7A, 9A and 11A, effective 4 April 2012.

(2)
A substance is a controlled drug if the substance (the drug analogue ) is, in relation to a controlled drug listed in subsection (1) (or a stereoisomer, a structural isomer (with the same constituent groups) or an alkaloid of such a controlled drug):

(a) a stereoisomer; or

(b) a structural isomer having the same constituent groups; or

(c) an alkaloid; or

(d) a structural modification obtained by the addition of one or more of the following groups:

(i) alkoxy, cyclic diether, acyl, acyloxy, mono-amino or dialkylamino groups with up to 6 carbon atoms in any alkyl residue;

(ii) alkyl, alkenyl or alkynyl groups with up to 6 carbon atoms in the group, where the group is attached to oxygen (for example, an ester or an ether group), nitrogen, sulphur or carbon;

(iii) halogen, hydroxy, nitro or amino groups; or

(e) a structural modification obtained in one or more of the following ways:

(i) by the replacement of up to 2 carbocyclic or heterocyclic ring structures with different carbocyclic or heterocyclic ring structures;

(ii) by the addition of hydrogen atoms to one or more unsaturated bonds;

(iii) by the replacement of one or more of the groups specified in paragraph (d) with another such group or groups;

(iv) by the conversion of a carboxyl or an ester group into an amide group; or

(f) otherwise a homologue, analogue, chemical derivative or substance substantially similar in chemical structure;

however obtained, except where the drug analogue is separately listed in subsection (1).

(3)
The trafficable quantity for a drug analogue described in subsection (2) is:

(a) unless paragraph (b) applies - the trafficable quantity set out in the table in subsection (1) for the controlled drug to which the drug analogue relates (whether directly or indirectly); or

(b) if the drug analogue relates to more than one controlled drug listed in the table in subsection (1) - the smallest trafficable quantity set out in the table in subsection (1) for any of those controlled drugs.

(4)
The marketable quantity for a drug analogue described in subsection (2) is:

(a) unless paragraph (b) applies - the marketable quantity set out in the table in subsection (1) for the controlled drug to which the drug analogue relates (whether directly or indirectly); or

(b) if the drug analogue relates to more than one controlled drug listed in the table in subsection (1) - the smallest marketable quantity set out in the table in subsection (1) for any of those controlled drugs.

(5)
The commercial quantity for a drug analogue described in subsection (2) is:

(a) unless paragraph (b) applies - the commercial quantity set out in the table in subsection (1) for the controlled drug to which the drug analogue relates (whether directly or indirectly); or

(b) if the drug analogue relates to more than one controlled drug listed in the table in subsection (1) - the smallest commercial quantity set out in the table in subsection (1) for any of those controlled drugs.

 View history note

 Hide history note

History

S 314.1 inserted by No 129 of 2005, s 3 and Sch 1 item 1, effective 6 December 2005.

SECTION 314.2 SECTION 314.2 Controlled plants  
314.2
The following table lists controlled plants and set out quantities:

Controlled plants and quantities
Controlled plant	Trafficable	Marketable	Commercial
	quantity	quantity	quantity
1     Any plant of the genus Cannabis	250 g or 10 plants	25 kg or 100 plants	250 kg or 1,000 plants

 View history note

 Hide history note

History

S 314.2 inserted by No 129 of 2005, s 3 and Sch 1 item 1, effective 6 December 2005.

SECTION 314.3 Controlled precursors  
(1)
The following table lists controlled precursors and sets out quantities:

Controlled precursors and quantities
Controlled precursor	Marketable	Commercial
	quantity	quantity
	(grams)	(kilograms)
1     Ephedrine	400.0	1.2
2     Ergometrine	0.15	0.006
3     Ergotamine	0.25	0.01
4     Isosafrole	290.0	1.45
5     Lysergic acid	0.075	0.003
6     3,4-Methylenedioxyphenylacetic acid	300.0	1.5
7     3,4-Methylenedioxyphenyl-2-propanone	150.0	0.75
8     Phenylacetic acid	1,350.0	4.05
8A     Phenylpropanolamine	400.0	1.2
9     Phenyl-2-propanone	675.0	2.03
10   Piperonal	320.0	1.6
11   Pseudoephedrine	400.0	1.2
12   Safrole	570.0	2.85

 View history note

 Hide history note

History

S 314.3(1) amended by No 24 of 2012, s 3 and Sch 5 item 5, by inserting table item 8A, effective 4 April 2012.

(2)
A substance is a controlled precursor if the substance is a salt or ester of a precursor listed in the table in subsection (1).

 View history note

 Hide history note

History

S 314.3 inserted by No 129 of 2005, s 3 and Sch 1 item 1, effective 6 December 2005.

SECTION 314.4 Border controlled drugs  
(1)
The following table lists border controlled drugs and sets out quantities:

Controlled precursors and quantities
Controlled precursor	Marketable	Commercial
	quantity	quantity
	(grams)	(grams)
1     Acetorphine	2.0	2.0
2     Acetyl-alpha-methylfentanyl	0.005	0.005
3     Acetylcodeine	2.0	2.0
4     Acetyldihydrocodeine	2.0	2.0
5     Acetylmethadol	2.0	2.0
6     Allylprodine	2.0	2.0
7     Alphacetylmethadol	10.0	10.0
8     Alphameprodine	0.2	0.2
9     Alphamethadol	0.2	0.2
10   alpha-Methylfentanyl	0.005	0.005
11   alpha-Methylthiofentanyl	0.005	0.005
12   Alphaprodine	25.0	25.0
13   Amphecloral	2.0	2.0
14   3-(2-Aminopropyl)indole (alpha-methyltryptamine (AMT))	2.0	2.0
15   Amphetamine	2.0	0.75
16   Anileridine	25.0	25.0
17   Barbiturates	50.0	5.0
18   Benzethidine	10.0	10.0
19   Benzoylecgonine	2.0	2.0
20   Benzylmorphine	5.0	5.0
20A   Benzylpiperazine (BZP)	2.0	0.75
21   Betacetylmethadol	5.0	5.0
22   beta-Hydroxyfentanyl	0.005	0.005
23   beta-Hydroxy-3-methylfentanyl	0.005	0.005
24   Betameprodine	5.0	5.0
25   Betamethadol	5.0	5.0
26   Betaprodine	5.0	5.0
27   Bezitramide	5.0	5.0
28   4-Bromo-2,5-dimethoxy amphetamine	0.5	0.5
29   Bufotenine	2.0	2.0
30   Cannabinoids (other than a Cannabinoid of a kind that can be obtained from a plant that is not a Cannabis plant)	2.0	2.0
31   Cannabis (in any form, including flowering or fruiting tops, leaves, seeds or stalks, but not including Cannabis resin or Cannabis fibre)	25,000.0	100.0
32   Cannabis resin	20.0	50.0
33   Chlorophentermine	2.0	2.0
34   Clonitazene	5.0	5.0
35   Cocaine	2.0	2.0
36   Codeine	10.0	10.0
37   Codeine-N-oxide	10.0	10.0
38   Codoxime	10.0	10.0
39   Desomorphine	2.0	2.0
40   Dexamphetamine	2.0	2.0
41   Dextromoramide	2.0	2.0
42   2,5-Dimethoxy-4-n-propylthiophenethylamine (2C-T-7)	0.5	0.5
43   2,5-Dimethoxy-4-ethylthiophenethylamine (2C-T-2)	0.5	0.5
44   2,5-Dimethoxy-4-iodophenethylamine (2C-I)	0.5	0.5
45   Diampromide	5.0	5.0
46   Diethylpropion	5.0	5.0
47   Diethylthiambutene	5.0	5.0
48   N,N-Diethyltryptamine	2.0	2.0
49   Difenoxin	2.0	2.0
50   Dihydrocodeine	10.0	10.0
51   Dihydromorphine	10.0	10.0
52   Dimenoxadol	10.0	10.0
53   Dimepheptanol	10.0	10.0
54   2,5-Dimethoxy-4-methyl amphetamine	2.0	0.75
55   1-Dimethylamino-1,2-diphenyl ethane	5.0	5.0
56   Dimethylthiambutene	20.0	20.0
57   N,N-Dimethyltryptamine	2.0	2.0
58   Dioxaphetyl butyrate	2.0	2.0
59   Diphenoxylate	2.0	2.0
60   Dipipanone	10.0	10.0
61   Drotebanol	2.0	2.0
62   Ecgonine	10.0	10.0
63   Ethchlorvynol	50.0	50.0
64   Ethinamate	50.0	50.0
65   Ethylmethylthiambutene	10.0	10.0
66   Ethylmorphine	2.0	2.0
67   Etonitazene	5.0	5.0
68   Etorphine	5.0	5.0
69   Etoxeridine	5.0	5.0
70   Fentanyl	0.005	0.005
71   Furethidine	1.0	1.0
72   Gammabutyrolactone (GBL)	2.0	1.0
73   Glutethimide	50.0	50.0
74   Harmaline	2.0	5.0
75   Harmine	2.0	5.0
76   Heroin (diacetylmorphine)	2.0	1.5
77   Hydrocodone	2.0	2.0
78   Hydromorphinol	2.0	2.0
79   Hydromorphone	2.0	2.0
80   Hydroxyamphetamine	2.0	2.0
81   4-Hydroxybutanoic acid (GHB)	2.0	1.0
82   Hydroxypethidine	5.0	5.0
83   Isomethadone	2.0	2.0
83A   Ketamine	3.0	1.0
84   Ketobemidone	2.0	2.0
85   Levophenacylmorphan	2.0	2.0
86   Levomethorphan, but not including dextromethorphan	2.0	2.0
87   Levorphanol, but not including dextrorphan	1.0	1.0
88   Lysergamide	0.1	0.01
89   Lysergide (LSD)	0.002	0.002
90   Meprobamate	50.0	50.0
91   Mescaline	7.5	7.5
92   Metazocine	7.0	7.0
93   Methadone	2.0	2.0
93A   Methamphetamine	2.0	0.75
94   Methaqualone	50.0	5.0
95   Methcathinone	2.0	0.75
96   Methorphan, but not including dextromethorphan	2.0	2.0
97   5-Methoxy-alpha-methyltrypt amine (5-MeO-AMT)	2.0	2.0
98   5-Methoxy-N,N-diisopropyl tryptamine (5-MeO-DiPT)	2.0	2.0
99   (Repealed by No 24 of 2012)
100   3,4-Methylenedioxyamphetamine (MDA)	0.5	0.75
101   3,4-Methylenedioxymethamphet amine (MDMA)	0.5	0.5
102   Methyldesorphine	2.0	2.0
103   Methyldihydromorphine	2.0	2.0
104   3-Methylfentanyl	0.005	0.005
104A   4-Methylmethcathinone (4-MMC)	2.0	0.75
105   Methylphenidate	2.0	2.0
106   1-Methyl-4-phenyl-4-propion oxypiperidine (MPPP)	2.0	2.0
107   3-Methylthiofentanyl	0.005	0.005
108   Methyprylon	50.0	50.0
109   Metopon	2.0	2.0
110   Monoacetylmorphines	2.0	2.0
111   Moramide	2.0	2.0
112   Morphan, but not including dextrorphan	2.0	2.0
113   Morpheridine	2.0	2.0
114   Morphine	2.0	1.5
115   Morphine-N-oxide	2.0	2.0
116   Myrophine	20.0	20.0
117   Nicocodine	2.0	2.0
118   Nicodicodine	2.0	2.0
119   Nicomorphine	2.0	2.0
120   Noracymethadol	2.0	2.0
121   Norcodeine	2.0	2.0
122   Norlevorphanol	2.0	2.0
123   Normethadone	5.0	5.0
124   Normorphine	20.0	20.0
125   Norpipanone	10.0	10.0
126   Opium	20.0	20.0
127   Oxycodone	5.0	5.0
128   Oxymorphone	2.0	2.0
129   para-Fluorofentanyl	0.005	0.005
130   Pentazocine	20.0	20.0
131   Pethidine	10.0	10.0
132   Phenadoxone	10.0	10.0
133   Phenampromide	10.0	10.0
134   Phenazocine	1.0	1.0
135   Phencyclidine	2.0	2.0
136   Phendimetrazine	5.0	5.0
137   Phenmetrazine	5.0	5.0
138   Phenomorphan	5.0	5.0
139   Phenoperidine	1.0	1.0
140   Phentermine	5.0	5.0
141   1-Phenylethyl-4-phenyl-4-ace toxypiperidine (PEPAP)	2.0	2.0
142   Pholcodine	5.0	5.0
143   Piminodine	10.0	10.0
144   Pipradrol	1.0	1.0
145   Piritramide	1.0	1.0
146   Proheptazine	1.0	1.0
147   Properidine	25.0	25.0
148   Propiram	10.0	10.0
149   Psilocine	0.1	0.1
150   Psilocybine	0.1	0.1
151   Tetrahydrocannabinols	2.0	5.0
152   Thebacon	2.0	2.0
153   Thebaine	2.0	2.0
154   Thiofentanyl	0.005	0.005
155   Trimeperidine	10.0	10.0

 View history note

 Hide history note

History

S 314.4(1) amended by No 24 of 2012, s 3 and Sch 5 items 6 - 11, by inserting table items 20A, 83A, 93A and 104A, substituting table item 95 and repealing table item 99, effective 4 April 2012. Table items 95 and 99 formerly read:

95   Methcathinone
99   Methamphetamine	2.0	0.75

(2)
A substance is also a border controlled drug if the substance (the drug analogue ) is, in relation to a border controlled drug listed in subsection (1) (or a stereoisomer, a structural isomer (with the same constituent groups) or an alkaloid of such a border controlled drug):

(a) a stereoisomer; or

(b) a structural isomer having the same constituent groups; or

(c) an alkaloid; or

(d) a structural modification obtained by the addition of one or more of the following groups:

(i) alkoxy, cyclic diether, acyl, acyloxy, mono-animo or dialkylamino groups with up to 6 carbon atoms in any alkyl residue;

(ii) alkyl, alkenyl or alkynyl groups with up to 6 carbon atoms in the group, where the group is attached to oxygen (for example, an ester or an ether group), nitrogen, sulphur or carbon;

(iii) halogen, hydroxy, nitro or amino groups; or

(e) a structural modification obtained in one or more of the following ways:

(i) by the replacement of up to 2 carbocyclic or heterocyclic ring structures with different carbocyclic or heterocyclic ring structures;

(ii) by the addition of hydrogen atoms to one or more unsaturated bonds;

(iii) by the replacement of one or more of the groups specified in paragraph (d) with another such group or groups;

(iv) by the conversion of a carboxyl or an ester group into an amide group; or

(f) otherwise a homologue, analogue, chemical derivative or substance substantially similar in chemical structure;

however obtained, except where the drug analogue is separately listed in subsection (1).

(3)
The marketable quantity for a drug analogue described in subsection (2) is:

(a) unless paragraph (b) applies - the marketable quantity specified in the table in subsection (1) for the border controlled drug to which the drug analogue relates (whether directly or indirectly); or

(b) if the drug analogue relates to more than one border controlled drug listed in the table in subsection (1) - the smallest marketable quantity specified in the table in subsection (1) for any of those border controlled drugs.

(4)
The commercial quantity for a drug analogue described in subsection (2) is:

(a) unless paragraph (b) applies - the commercial quantity specified in the table in subsection (1) for the border controlled drug to which the drug analogue relates (whether directly or indirectly); or

(b) if the drug analogue relates to more than one border controlled drug listed in the table in subsection (1) - the smallest commercial quantity specified in the table in subsection (1) for any of those border controlled drugs.

 View history note

 Hide history note

History

S 314.4 inserted by No 129 of 2005, s 3 and Sch 1 item 1, effective 6 December 2005.

SECTION 314.5 SECTION 314.5 Border controlled plants  
314.5
The following table lists border controlled plants and sets out quantities:

Border controlled plants and quantities
Border controlled precursor	Marketable	Commercial
	quantity	quantity
1     Any plant of the genus Cannabis	25 kg or 100 plants	250 kg or 1,000 plants
2     Any plant of the genus Erythroxylon (also known as Erythroxylum) from which cocaine can be extracted either directly or by chemical transformation	80 kg
3     Any plant of the genus Lophophora
4     Any plant of the species Papaver bracteatum	10 kg
5     Any plant of the species Papaver somniferum	10 kg
6     Any plant of the species Piptagenia peregrine
7     Any plant of the species Psilocybe

 View history note

 Hide history note

History

S 314.5 inserted by No 129 of 2005, s 3 and Sch 1 item 1, effective 6 December 2005.

SECTION 314.6 Border controlled precursors  
(1)
The following table lists border controlled precursors and sets out quantities:

Border controlled precursors and quantities
Border controlled precursors	Marketable	Commercial
	quantity	quantity
	(grams)	(kilograms)
1     N-Acetylanthranilic acid
2     Any plant of the species Ephedra
3     Ephedrine	3.2	1.2
4     Ergometrine	0.006	0.006
5     Ergotamine	0.01	0.01
6     Isosafrole	1.45	1.45
7     Lysergic acid	0.003	0.003
8     3,4-Methylenedioxyphenyl-2-propanone	0.75	0.75
9     Phenylacetic acid	10.8	4.05
10   Phenylpropanolamine	3.2	1.2
11   Phenyl-2-propanone	5.4	2.03
12   Piperonal	1.6	1.6
13   Pseudoephedrine	3.2	1.2
14   Safrole	2.85	2.85

 View history note

 Hide history note

History

S 314.6(1) amended by No 24 of 2012, s 3 and Sch 5 item 12, by substituting table item 10, effective 4 April 2012. Table item 10 formerly read:

10   Phenylpropanolamine

(2)
A substance is a border controlled precursor if the substance is a salt or ester of a precursor listed in the table in subsection (1).

(3)
A substance is a border controlled precursor if the substance is a chemical or compound, other than a chemical or compound that is listed in a table in this Division, that, in the manufacture by a chemical process of a chemical or compound referred to in the table in subsection (1), is an immediate precursor of that chemical or compound.

 View history note

 Hide history note

History

S 314.6 inserted by No 129 of 2005, s 3 and Sch 1 item 1, effective 6 December 2005.

Div 314 inserted by No 129 of 2005, s 3 and Sch 1 item 1, effective 6 December 2005.

S 314.1(1) amended by No 24 of 2012, s 3 and Sch 5 items 1 - 4, by inserting table items 1A, 7A, 9A and 11A, effective 4 April 2012.

S 314.1 inserted by No 129 of 2005, s 3 and Sch 1 item 1, effective 6 December 2005.